Literature DB >> 29391899

CoCl2 increases the expression of hypoxic markers HIF-1α, VEGF and CXCR4 in breast cancer MCF-7 cells.

Qing Li1, Rong Ma1, Mei Zhang1.   

Abstract

The aim of the present study was to investigate the effect of a hypoxic environment on the biological behavior of breast cancer MCF-7 cells, using CoCl2 to mimic the hypoxia model in breast cancer cells. Using 50, 100, 150 and 200 µM CoCl2 as a hypoxic inducer, a hypoxic model was established in MCF-7 cells in vitro. MTT, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) and western blotting assays were performed to detect MCF-7 cell proliferation under hypoxic conditions and the expression of the hypoxic markers hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and C-X-C motif chemokine receptor 4 (CXCR4) mRNA and that of the associated proteins. The RT-qPCR results revealed that there were no obvious changes in the expression of HIF-1α mRNA; however, the expression of CXCR4 and VEGF mRNA increased significantly following treatment with different CoCl2 concentrations (P<0.05). The results of western blotting identified that CoCl2 significantly induced the expression of HIF-1α, CXCR4 and VEGF proteins (P<0.05). The MTT assay revealed that different concentrations of CoCl2 inhibited the proliferation of MCF-7 cells. The TUNEL assay demonstrated that CoCl2 was able to trigger apoptosis of MCF-7 cells. Therefore, the results of the present study identified that CoCl2 is able to control MCF-7 cell proliferation and apoptosis, also increasing the expression of HIF-1α, CXCR4 and VEGF. The present study may aid the discovery of a novel method to prevent cell damage and decrease cell proliferation in order to prevent the occurrence and development of breast cancer.

Entities:  

Keywords:  C-X-C motif chemokine receptor 4; CoCl2; MCF-7 cell; breast cancer; cell proliferation; hypoxia model; hypoxia-inducible factor-1α; vascular endothelial growth factor

Year:  2017        PMID: 29391899      PMCID: PMC5769392          DOI: 10.3892/ol.2017.7369

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

3.  Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection.

Authors:  Daisaku Yamada; Shogo Kobayashi; Hirofumi Yamamoto; Yoshito Tomimaru; Takehiro Noda; Mamoru Uemura; Hiroshi Wada; Shigeru Marubashi; Hidetoshi Eguchi; Masahiro Tanemura; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  Ann Surg Oncol       Date:  2011-05-24       Impact factor: 5.344

4.  RNA interference for HIF-1alpha inhibits its downstream signalling and affects cellular proliferation.

Authors:  Jörg Hänze; Bastian G Eul; Rajkumar Savai; Stefanie Krick; Parag Goyal; Friedrich Grimminger; Werner Seeger; Frank Rose
Journal:  Biochem Biophys Res Commun       Date:  2003-12-19       Impact factor: 3.575

5.  Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair.

Authors:  D E Komatsu; M Hadjiargyrou
Journal:  Bone       Date:  2004-04       Impact factor: 4.398

6.  Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via Hypoxia-Inducible Factor 1α.

Authors:  Cynthia Lopez-Haber; Laura Barrio-Real; Victoria Casado-Medrano; Marcelo G Kazanietz
Journal:  Mol Cell Biol       Date:  2016-07-14       Impact factor: 4.272

Review 7.  Breast cancer as a global health concern.

Authors:  Steven S Coughlin; Donatus U Ekwueme
Journal:  Cancer Epidemiol       Date:  2009-11-07       Impact factor: 2.984

8.  Cobalt chloride and low oxygen tension trigger differentiation of acute myeloid leukemic cells: possible mediation of hypoxia-inducible factor-1alpha.

Authors:  Y Huang; K-M Du; Z-H Xue; H Yan; D Li; W Liu; Z Chen; Q Zhao; J-H Tong; Y-S Zhu; G-Q Chen
Journal:  Leukemia       Date:  2003-11       Impact factor: 11.528

9.  Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.

Authors:  Lauren K Dunn; Khalid S Mohammad; Pierrick G J Fournier; C Ryan McKenna; Holly W Davis; Maria Niewolna; Xiang Hong Peng; John M Chirgwin; Theresa A Guise
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

10.  Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?

Authors:  Günther Gruber; Richard H Greiner; Ruslan Hlushchuk; Daniel M Aebersold; Hans J Altermatt; Gilles Berclaz; Valentin Djonov
Journal:  Breast Cancer Res       Date:  2004-03-09       Impact factor: 6.466

View more
  10 in total

1.  The Effect of Deoxycholic Acid on Chitosan-Enabled Matrices for Tissue Scaffolding and Injectable Nanogels.

Authors:  Bozica Kovacevic; Corina Mihaela Ionescu; Melissa Jones; Susbin Raj Wagle; Michael Lewkowicz; Maja Đanić; Momir Mikov; Armin Mooranian; Hani Al-Salami
Journal:  Gels       Date:  2022-06-07

2.  CXCL10 is a novel anti-angiogenic factor downstream of p53 in cardiomyocytes.

Authors:  Tri Wahyuni; Shota Tanaka; Ryuta Igarashi; Yoshiaki Miyake; Ayaha Yamamoto; Shota Mori; Yusuke Kametani; Masashi Tomimatsu; Shota Suzuki; Kosei Yokota; Yoshiaki Okada; Makiko Maeda; Masanori Obana; Yasushi Fujio
Journal:  Physiol Rep       Date:  2022-05

3.  Autophagy/ Apoptosis Induced by Geraniol through HIF-1α/BNIP3/Beclin-1 Signaling Pathway in A549 CoCl2 Treated Cells.

Authors:  Dina M Abo El-Ella
Journal:  Adv Pharm Bull       Date:  2020-10-18

4.  Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation.

Authors:  Aneesha Polisety; Gauri Misra; Jyotika Rajawat; Amit Katiyar; Harpreet Singh; Anant Narayan Bhatt
Journal:  Med Oncol       Date:  2022-05-23       Impact factor: 3.738

5.  Cobalt (II) Chloride Regulates the Invasion and Survival of Brucella abortus 544 in RAW 264.7 Cells and B6 Mice.

Authors:  Tran X N Huy; Trang T Nguyen; Alisha W B Reyes; Heejin Kim; WonGi Min; Hu J Lee; John H Lee; Suk Kim
Journal:  Pathogens       Date:  2022-05-18

6.  Proangiogenic Hypoxia-Mimicking Agents Attenuate Osteogenic Potential of Adipose Stem/Stromal Cells.

Authors:  Ahmed G Abu-Shahba; Arjen Gebraad; Sippy Kaur; Riku O Paananen; Hilkka Peltoniemi; Riitta Seppänen-Kaijansinkko; Bettina Mannerström
Journal:  Tissue Eng Regen Med       Date:  2020-05-24       Impact factor: 4.169

7.  Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming.

Authors:  Jinmei Jin; Shuiping Qiu; Ping Wang; Xiaohui Liang; Fei Huang; Hui Wu; Beibei Zhang; Weidong Zhang; Xinhui Tian; Ren Xu; Hailian Shi; Xiaojun Wu
Journal:  J Exp Clin Cancer Res       Date:  2019-08-27

8.  Uncovering emergent phenotypes in endothelial cells by clustering of surrogates of cardiovascular risk factors.

Authors:  Iguaracy Pinheiro-de-Sousa; Miriam H Fonseca-Alaniz; Samantha K Teixeira; Mariliza V Rodrigues; Jose E Krieger
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

9.  Amniotic growth factors enhanced human pre-adipocyte cell viability and differentiation under hypoxia.

Authors:  Alejandro Magana; Regina Giovanni; Edidiong Essien; Boris Epel; Mrignayani Kotecha; Songyun Liu; Mathew T Mathew; Sarah E Hagarty; Divya Bijukumar
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2022-04-06       Impact factor: 3.405

10.  Resveratrol attenuates hypoxia-induced neuronal cell death, inflammation and mitochondrial oxidative stress by modulation of TRPM2 channel.

Authors:  Yener Akyuva; Mustafa Nazıroğlu
Journal:  Sci Rep       Date:  2020-04-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.